In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Cancer Type/Condition:  Lymphoma, Hodgkin lymphoma, child
Stage/Subtype:  stage I childhood Hodgkin lymphoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, NCT01231412
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 95-024, P30CA008748, MSKCC-95024, NCI-V95-0685, NCT00002663
3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: BCM-H-19386, BCM-FAB, H 19386, NCT00625144
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 74
Sponsor: NCI
Protocol IDs: 080051, 08-C-0051, NCT00923910
5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 montha to 70
Sponsor: Other
Protocol IDs: J1055, NA_00039823, NCT01203722
6.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 70
Sponsor: Other
Protocol IDs: 2005LS048, UMN-0508M72589, UMN-MT2004-24, UMN-2005LS048, NCT00345865
7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 70 years old and under
Sponsor: Other
Protocol IDs: CDR0000538185, CCCWFU-29506, IRB00001366, CCCWFU-IRB00001366, NCT00453206
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HOD08, NCT00846742
9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: UFPTI 0806 - HL01, NCT00850200
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCT01010217
11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 26
Sponsor: Other
Protocol IDs: L 10,321, NYMC 525, NCT01049854
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P01CA018029, NCT01251575
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: UCBT01, NCT01328496
14.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: any age
Sponsor: Other
Protocol IDs: 11-130, NCT01498484
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 2 to 70
Sponsor: Other
Protocol IDs: 12-153, NCT01682226
16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 22 and under
Sponsor: Other
Protocol IDs: CHOP 07/216, NCT01071226
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 10 to 75
Sponsor: Other
Protocol IDs: 2012-0170, NCT01749293
18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: HAPNK1, NCT01807611
19.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, NHLBI, NIAID, Other
Protocol IDs: 130116, 13-H-0116, NCT01861093
20.

Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 22899-ATECRAB, NCT00709033
21.

Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 9936-ALCI, NCT00062868
22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 26617-CAR CD 30, NCT01192464
23.

Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: H-28361-MALTED, MALTED, NCT01447056
24.

Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: H-29617-GRALE, GRALE, NCT01555892
25.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 6 and over
Sponsor: Other
Protocol IDs: 12-346, NCT01751412
New Search